Article citationsMore>>

Yoshikawa, T., Morita, S., Tanabe, K., Nishikawa, K., Ito, Y., Matsui, T., et al. (2016) Survival Results of a Randomised Two-by-Two Factorial Phase II Trial Comparing Neoadjuvant Chemotherapy with Two and Four Courses of S-1 plus Cisplatin (SC) and Paclitaxel plus Cisplatin (PC) Followed by D2 Gastrectomy for Resectable Advanced Gastric Cancer. European Journal of Cancer, 62, 103-111.
https://doi.org/10.1016/j.ejca.2016.04.012

has been cited by the following article:

• TITLE: Current Status and Research Progress of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer

  AUTHORS: Junjian Liu, Tian Wei, Zhiping Xiang, Yinlu Ding

  KEYWORDS: Locally Advanced Gastric Cancer, Adjuvant Chemotherapy, Neoadjuvant Chemotherapy

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.11 No.3, March 30, 2023

  ABSTRACT: Gastric cancer is one of the most common malignant tumours worldwide, with a high degree of malignancy and a poor prognosis. While early gastric cancer can be cured by surgical treatment, locally advanced gastric cancer requires neoadjuvant therapy to shrink the tumour, suppress potential metastases, achieve down-staging, and provide patients with the opportunity for radical surgery to prolong their survival. This article reviews the current status and progress of neoadjuvant chemotherapy for locally advanced gastric cancer.